Investor Ideas Snapshot; NASDAQ Top Percentage Gainers; (EMITF), (GLUU), (TLF), (CDXS)
Ideas get bigger when you share them...
Visit: Elbit Imaging Ltd.
New York, New York - March 12, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for March 12th, 2013.
Elbit Imaging Ltd., (NASDAQ:EMITF) trading at $2.59 moved up $0.41 or 18.81% on a volume of 22,083 shares, making it today's top percentage gainer on the NASDAQ.
Elbit Imaging Ltd. Announced earlier today that the Tel Aviv District Court appointed Mr. Ron Alroy, CPA, as an expert following a petition filed by the Trustees of the Company's outstanding Series C, D, E, F and Series 1 Notes, with respect to the negotiations regarding a restructuring of the debt of the Company as announced by the Company on February 27 th, 2013
Glu Mobile Inc., (NASDAQ:GLUU) trading at $2.84 gained $0.42 or 17.36% on a high volume of 15,743,238 shares.
Shares of Glu Mobile jumped up earlier this morning after the developer of mobile games announced that it has launched its first real-money gambling offering in the U.K. In a statement, Glu said it has partnered with Probability plc to launch a mobile slot game featuring intellectual property from its "Samurai vs. Zombies Defense" title.
Tandy Leather Factory Inc., (NASDAQ:TLF) trading at $6.91 rose $0.74 or 12.03% on a volume of 35,508 shares.
Tandy Leather Factory saw fourth-quarter net income jump 29 percent as the retailer continues to expand the size of its stores to boost sales.
Tandy earned $2.2 million, or 22 cents per share, for the three months ended Dec. 31 which is up from $1.7 million, or 17 cents per share, a year earlier. Revenue also increased 9 percent to $20.6 million, after dipping in 2007, it has jumped every year since the company posted annual sales of $53.3 million in 2008. At the end of 2012, revenue totaled $72.7 million, up 10 percent from the previous year.
Codexis Inc., (NASDAQ:CDXS) trading at $2.56 gained $0.25 or 10.82% on a volume of 128,677 shares.
Codexis, Inc., a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, announced earlier today the launch of CodeXyme® 4 and CodeXyme® 4X cellulase enzyme packages for use in producing cellulosic sugar for production of biofuels and bio-based chemicals.
Codexis' latest generation of advanced cellulase enzymes, CodeXyme® 4 for dilute acid pretreatments and CodeXyme®4X for hydrothermal pretreatments, exhibits excellent performance, converting up to 85% of available fermentable sugars at high biomass and low enzyme loads. Combined with high strain productivity using the CodeXporter® enzyme production system, this allows for a cost-in-use that the company believes will be among the lowest available once in full-scale commercial production.
CodeXyme® 4 increases performance 10-20% over Codexis' last generation product, CodeXyme® 3, measured by the amount of glucan converted into C6 fermentable sugar. For pre-treatments with unconverted xylan, CodeXyme® 4X maintains the same high C6 sugar activity while having additional C5 sugar conversion.
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
Become an Investorideas.com Member and access our online stock directories listing thousands of publicly traded stocks in over 14 leading sectors
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com